Medical Devices Startups
5,183 companies tagged Medical Devices, with their investors and founders.
Allotrope Medical makes electrical stimulation devices that integrate with surgical instruments to help surgeons visualize and assess urinary and digestive system structures during procedures. The technology targets surgeons performing abdominal and pelvic operations.
3 investors
Allurion offers a weight-loss program built around a swallowable, procedureless gastric balloon combined with nutrition coaching, connected digital tools, and AI-driven clinician support. It serves patients seeking non-surgical obesity treatment and works through a network of accredited clinics.
3 investors
Altay Therapeutics develops small molecule inhibitors targeting transcription factors to treat serious diseases including facioscapulohumeral muscular dystrophy and cancer. The company's pipeline includes oral drug candidates designed as first- or best-in-class therapeutics for oncology and inflammatory conditions.
3 investors
3 investors
AmacaThera is a biotech company developing a tunable injectable hydrogel drug-delivery platform, based on hyaluronic acid and methylcellulose, for localized and long-acting release of therapeutics such as small molecules, biologics, peptides, and cells. It partners with pharmaceutical companies to co-develop products across applications including post-surgical non-opioid pain management and oncology.
3 investors
Amann Girrbach develops dental technologies including high-precision machines and materials for digital dentistry, serving dental technicians and practitioners. It provides equipment, materials, a global technical service network across more than 90 countries, and training through its online academy.
3 investors
XRHealth provides telehealth therapy delivered at home using FDA-registered VR/AR headsets, mobile apps, wearables, and prescription digital therapeutics (such as Stanza), combined with licensed clinicians. It focuses on chronic pain and fibromyalgia, along with mental health, physical rehabilitation, and cognitive training, with programs covered by insurance in the United States.</parameter> <parameter name="hq_country">US
3 investors
Anja Health provides cord blood banking and stem cell storage services from umbilical cords and placentas for families. The company aims to make stem cell preservation accessible and affordable for new parents.
3 investors
Annaida develops an AI-driven metabolomic platform using microscale magnetic resonance spectroscopy (MRS) to noninvasively analyze embryos and oocytes and support embryo selection. It serves fertility clinics and researchers with metabolic screening for personalized fertility treatments.
3 investors
Append Medical develops a transcatheter system using vacuum-based technology to treat non-valvular atrial fibrillation by occluding the left atrial appendage without implanting a device in the heart. The system aims to reduce stroke risk in cardiac patients by eliminating device-related thromboembolism and peri-device leakage complications.
3 investors
APR is a South Korean beauty-tech company that develops and manufactures beauty devices (such as EMS, HIFU, and radio-frequency skincare devices under its Medicube AGE-R line) alongside cosmetics, fragrance, and fashion brands including APRILSKIN, Medicube, Forment, and NERDY. The company sells through its own direct-to-consumer online stores and operates internationally with subsidiaries across Asia and the US.
3 investors
Arda develops therapeutics using single-cell computational biology to target and eliminate pathogenic cells in chronic diseases. The company combines drug development expertise with cellular biology to create new therapeutic approaches.
3 investors
Artera develops AI-powered diagnostic tests that analyze patient biopsy images to predict therapeutic response in cancer care. The company enables personalized treatment decisions and shared decision-making between clinicians and patients, beginning with localized prostate cancer.
3 investors
Arterys provides AI clinical applications for medical imaging that integrate directly into existing PACS and EHR systems to assist physicians with diagnosis and treatment decisions. The platform is cloud-based and designed for radiology workflows in healthcare settings.
3 investors
Artos provides AI-powered software tools for Chemistry, Manufacturing, and Controls (CMC) teams in the pharmaceutical industry to draft, manage, and quality-check regulatory documentation. The platform uses specialized AI systems designed to handle dense tabular data and non-standard formats common in regulatory Module 3 documents.
3 investors
Aspero Medical develops the Pillar balloon overtube solution with micro-textured design to improve control and anchoring during balloon endoscopy for small bowel diagnosis and treatment. The technology reduces procedure time and sedation requirements for gastrointestinal interventions.
3 investors
Astek Diagnostics develops a diagnostic platform for rapid and accurate detection of urinary tract infections and related conditions in clinical specimens. The company serves physicians and patients needing point-of-care diagnostic solutions for infectious diseases.
3 investors
aTyr is a clinical-stage biotechnology company developing therapies derived from tRNA synthetase biology to treat fibrosis and inflammation, with its lead candidate efzofitimod in clinical trials for interstitial lung disease. The company leverages a proprietary discovery platform targeting immune-mediated disorders in pulmonary and systemic conditions.
3 investors
Audibene sells hearing aids and related digital solutions for people with hearing loss through Germany's largest network of partnered acousticians. The company combines smart hearing device technology with personalized consultation and audiologist services.
3 investors
Avammune is a drug discovery company developing novel therapeutics for hard-to-treat solid tumors using computational chemistry, immunology, and targeted radiotherapeutics. The company focuses on converting immunologically cold tumors into responsive ones and identifying new cancer dependencies as therapeutic targets.
3 investors
Avation Medical manufactures the Vivally System, an FDA-cleared wearable device that uses transcutaneous tibial nerve stimulation to treat overactive bladder and urge urinary incontinence in at-home 30-minute sessions. The device is prescribed by healthcare providers for patients seeking a non-invasive alternative to medications, injectables, or surgical implants.
3 investors
Avisi Technologies develops nanotechnology-enabled implantable devices to lower intraocular pressure in patients with open-angle glaucoma. Its products are investigational ophthalmic medical devices currently in clinical trials.
3 investors
Avivomed is a medical device company developing minimally invasive neuromodulation therapies for patients with obstructive sleep apnea. Based in the Minneapolis area, it targets mild-to-moderate OSA patients who cannot tolerate CPAP.
3 investors
Axithra develops a photonics-based device using Raman spectroscopy on a chip to measure the free, active fraction of drugs in patient blood for bedside therapeutic drug monitoring. The technology, aimed at healthcare professionals and targeting antibiotics, oncology drugs, and antifungals, is under development and clinical investigation and not yet commercially available.
3 investors